ERK1/2 inhibitors act as monovalent degraders inducing ubiquitylation and proteasome-dependent turnover of ERK2, but not ERK1
Kathryn Balmanno(Babraham Institute), Simon J. Cook(Babraham Institute)
Cited by 20
Related Papers
RapV12 antagonizes Ras‐dependent activation of ERK1 and ERK2 by LPA and EGF in Rat‐1 fibroblasts.
|The EMBO Journal|1993|352
Extracellular Signal-regulated Kinases 1/2 Are Serum-stimulated “BimEL Kinases” That Bind to the BH3-only Protein BimEL Causing Its Phosphorylation and Turnover
|Journal of Biological Chemistry|2004|187
ERK1/2‐dependent phosphorylation of BimEL promotes its rapid dissociation from Mcl‐1 and Bcl‐xL
|The EMBO Journal|2007|174
Adaptation to mTOR kinase inhibitors by amplification of eIF4E to maintain cap-dependent translation
|Journal of Cell Science|2013|78
Targeting melanoma’s MCL1 bias unleashes the apoptotic potential of BRAF and ERK1/2 pathway inhibitors
|Nature Communications|2019|73